Annual CFF:
$495.11M+$179.72M(+56.98%)Summary
- As of today, APGE annual cash from financing is $495.11 million, with the most recent change of +$179.72 million (+56.98%) on December 31, 2024.
- During the last 3 years, APGE annual cash from financing has risen by +$326.79 million (+194.15%).
- APGE annual cash from financing is now at all-time high.
Performance
APGE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$19.74M+$18.56M(+1572.71%)Summary
- As of today, APGE quarterly cash from financing is $19.74 million, with the most recent change of +$18.56 million (+1572.71%) on September 30, 2025.
- Over the past year, APGE quarterly cash from financing has increased by +$19.36 million (+5053.52%).
- APGE quarterly cash from financing is now -95.62% below its all-time high of $450.52 million, reached on March 31, 2024.
Performance
APGE Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$65.90M+$19.36M(+41.59%)Summary
- As of today, APGE TTM cash from financing is $65.90 million, with the most recent change of +$19.36 million (+41.59%) on September 30, 2025.
- Over the past year, APGE TTM cash from financing has dropped by -$384.64 million (-85.37%).
- APGE TTM cash from financing is now -91.41% below its all-time high of $767.46 million, reached on June 30, 2024.
Performance
APGE TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
APGE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +57.0% | +5053.5% | -85.4% |
| 3Y3 Years | +194.2% | +307.2% | +571.0% |
| 5Y5 Years | +194.2% | +294.8% | +1217.9% |
APGE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +194.2% | -95.6% | +1265.2% | -91.4% | +1990.0% |
| 5Y | 5-Year | at high | +194.2% | -95.6% | +1265.2% | -91.4% | +1990.0% |
| All-Time | All-Time | at high | +194.2% | -95.6% | +1265.2% | -91.4% | +1990.0% |
APGE Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $19.74M(+1572.7%) | $65.90M(+41.6%) |
| Jun 2025 | - | $1.18M(+89.7%) | $46.54M(+2.9%) |
| Mar 2025 | - | $622.00K(-98.6%) | $45.21M(-90.9%) |
| Dec 2024 | $495.11M(+57.0%) | $44.36M(>+9900.0%) | $495.11M(+9.9%) |
| Sep 2024 | - | $383.00K(+355.3%) | $450.54M(-41.3%) |
| Jun 2024 | - | -$150.00K(-100.0%) | $767.46M(+0.2%) |
| Mar 2024 | - | $450.52M(>+9900.0%) | $765.91M(+142.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $315.39M(+87.4%) | -$213.00K(-100.1%) | $315.39M(-0.1%) |
| Sep 2023 | - | $317.30M(>+9900.0%) | $315.60M(>+9900.0%) |
| Jun 2023 | - | -$1.69M(>-9900.0%) | $3.15M(-34.6%) |
| Mar 2023 | - | $0.00(-100.0%) | $4.82M(-50.9%) |
| Dec 2022 | $168.32M | - | - |
| Sep 2022 | - | $4.85M(>+9900.0%) | $9.82M(+97.4%) |
| Jun 2022 | - | -$26.00K(-100.5%) | $4.97M(-0.5%) |
| Mar 2022 | - | $5.00M | $5.00M |
FAQ
- What is Apogee Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Apogee Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Apogee Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of APGE is $495.11M
What is the all-time high annual cash from financing for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual cash from financing is $495.11M
What is Apogee Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, APGE annual cash from financing has changed by +$179.72M (+56.98%)
What is Apogee Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of APGE is $19.74M
What is the all-time high quarterly cash from financing for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly cash from financing is $450.52M
What is Apogee Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, APGE quarterly cash from financing has changed by +$19.36M (+5053.52%)
What is Apogee Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of APGE is $65.90M
What is the all-time high TTM cash from financing for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM cash from financing is $767.46M
What is Apogee Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, APGE TTM cash from financing has changed by -$384.64M (-85.37%)